Skip to Main Content

Paper Details

WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study.
Gynecol Oncol
6
2023
Author NameAffiliation
Neeltje SteeghsThe Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Jeroen de RidderCenter for Molecular Medicine and Oncode Institute, University Medical Center Utrecht
  • 1 - 2

Datasets

Release 1.2